Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types

Journal of Translational Medicine

Alessandro Lugli¹  Aurel Perren¹  Heather Dawson¹  Viktor H Koelzer¹  Inti Zlobec² 

[1] Clinical Pathology Division, Institute of Pathology, University of Bern, Murtenstrasse 31, Bern 3010, Switzerland;Translational Research Unit, Institute of Pathology, University of Bern, Murtenstrasse 31, Bern 3010, Switzerland

关键词: Pathology;    Automation;    Tumor microenvironment;    Next-generation;    Tissue microarray;   

Others  :  827643
DOI  :  10.1186/1479-5876-11-104

 received in 2013-03-13, accepted in 2013-04-23,  发布年份 2013

【 摘 要 】

Background

Tissue microarray (TMA) technology revolutionized the investigation of potential biomarkers from paraffin-embedded tissues. However, conventional TMA construction is laborious, time-consuming and imprecise. Next-generation tissue microarrays (ngTMA) combine histological expertise with digital pathology and automated tissue microarraying. The aim of this study was to test the feasibility of ngTMA for the investigation of biomarkers within the tumor microenvironment (tumor center and invasion front) of six tumor types, using CD3, CD8 and CD45RO as an example.

Methods

Ten cases each of malignant melanoma, lung, breast, gastric, prostate and colorectal cancers were reviewed. The most representative H&E slide was scanned and uploaded onto a digital slide management platform. Slides were viewed and seven TMA annotations of 1 mm in diameter were placed directly onto the digital slide. Different colors were used to identify the exact regions in normal tissue (n = 1), tumor center (n = 2), tumor front (n = 2), and tumor microenvironment at invasion front (n = 2) for subsequent punching. Donor blocks were loaded into an automated tissue microarrayer. Images of the donor block were superimposed with annotated digital slides. Exact annotated regions were punched out of each donor block and transferred into a TMA block. 420 tissue cores created two ngTMA blocks. H&E staining and immunohistochemistry for CD3, CD8 and CD45RO were performed.

Results

All 60 slides were scanned automatically (total time < 10 hours), uploaded and viewed. Annotation time was 1 hour. The 60 donor blocks were loaded into the tissue microarrayer, simultaneously. Alignment of donor block images and digital slides was possible in less than 2 minutes/case. Automated punching of tissue cores and transfer took 12 seconds/core. Total ngTMA construction time was 1.4 hours. Stains for H&E and CD3, CD8 and CD45RO highlighted the precision with which ngTMA could capture regions of tumor-stroma interaction of each cancer and the T-lymphocytic immune reaction within the tumor microenvironment.

Conclusion

Based on a manual selection criteria, ngTMA is able to precisely capture histological zones or cell types of interest in a precise and accurate way, aiding the pathological study of the tumor microenvironment. This approach would be advantageous for visualizing proteins, DNA, mRNA and microRNAs in specific cell types using in situ hybridization techniques.

【 授权许可】

   
2013 Zlobec et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Kallioniemi OP, Wagner U, Kononen J, Sauter G: Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001, 10:657.
• [2]Voduc D, Kenney C, Nielsen TO: Tissue microarrays in clinical oncology. Semin Radiat Oncol 2008, 18:89.
• [3]Fleischmann A, Rotzer D, Seiler R, Studer UE, Thalmann GN: Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol 2011, 60:350.
• [4]Tapia C: HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol 2004, 25:1551.
• [5]Zlobec I: Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008, 14:143.
• [6]Zlobec I: Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut 2008, 57:1413.
• [7]Rehemtulla A: Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration. Neoplasia 2012, 14:1278.
• [8]Galon J: Cancer classification using the Immunoscore: a worldwide task force. J Transl Med 2012, 10:205. BioMed Central Full Text